505 results on '"Astegiano, M"'
Search Results
2. Severe ulcerative colitis: predictors of response and algorithm proposal for rescue therapy
3. P391 THE DIAGNOSTIC CHALLENGE BETWEEN CHRONIC PULMONARY EMBOLISM AND PULMONARY ARTERY SARCOMA: A CASE REPORT
4. OC.15.2 SMALL BOWEL CARCINOMAS MAY COMPLICATE COELIAC DISEASE DESPITE STRICT ADHERENCE TO GLUTEN-FREE DIET: A CASE SERIES FROM THE SMALL BOWEL CANCER ITALIAN CONSORTIUM
5. PC.01.9 HYPOMETHYLATION OF LINE-1 IN SMALL BOWEL CARCINOMAS AND COELIAC DISEASE
6. T.05.10 CLINICAL HETEROGENEITY OF ADULT COELIAC DISEASE ACCORDING TO THE AGE AT ONSET: AN ITALIAN MULTICENTRIC STUDY
7. The practical management of chronic constipation as detected by a survey conducted on Italian gastroenterologists
8. P217 Volatile organic metabolites to predict clinical response to biological therapy in inflammatory bowel disease
9. Letter: therapeutic drug monitoring and inflammatory bowel disease—a call for an urgent standardization of the results
10. Letter: biologics treatment in Crohnʼs disease and risk of bowel resection—what about the patients who stop anti‐TNF therapy?
11. P301 Non-familial small bowel carcinomas in Crohnʼs disease: clinico-pathological, molecular and prognostic features
12. P178 Validation of the clinical utility of IFI16-based markers in IBD
13. T.03.3 FECAL SMALL NON-CODING RNAS AND MICROBIOME CHARACTERIZE PATIENTS WITH CELIAC DISEASE
14. P20 CARDIOMIOPATHY INDUCED BY ATRIAL FIBRILLATION: WHAT’S BEHIND IT?
15. P305 ACUTE MYOPERICARDITIS IN 2021: COVID19 RELATED?
16. P385 SYNCOPAL VENTRICULAR TACHYCARDIA IN HEALTHY HEART: AN UNUSUAL ORIGIN!
17. OC.09.2 VITAMIN D-RELATED GENETICS AS PREDICTOR OF RESPONSE TO ADALIMUMAB IN CROHN’S DISEASE
18. The mesenteric flap: a technique for pelvic closure after proctectomy for Crohnʼs disease
19. POS0230 INTESTINAL MICROBIOTA CHANGES TNF-INHIBITORS INDUCED IN IBD-RELATED SPONDYLOARTHRITIS
20. DOP20 Genetic of vitamin D as predictor of response to adalimumab in Crohn’s Disease
21. P164 Celiac Disease among a large cohort of inflammatory bowel disease patients: epidemiology and outcome implications
22. Correction: PD-L1 in small bowel adenocarcinoma is associated with etiology and tumor-infiltrating lymphocytes, in addition to microsatellite instability (Modern Pathology, (2020), 33, 7, (1398-1409), 10.1038/s41379-020-0497-0)
23. RELATIONSHIP BETWEEN ADALIMUMAB, PHARMACOKINETICS AND VITAMIN D-RELATED MARKERS
24. Interstitial and Granulomatous Lung Disease in Inflammatory Bowel Disease Patients
25. Efficacy and safety of oral beclomethasone dipropionate for ileal or ileal-right colon Crohn's disease of mild-to-moderate activity or in remission: Retrospective study
26. A preserved stratified pattern of the bowel wall 1 year after major surgery does not influence the surgical recurrence of Crohn’s disease
27. Activity of Crohn disease: value of Color-Power-Doppler and contrast-enhanced ultrasonography
28. OC.10.6 THE MOST INAPPROPRIATELY PRESCRIBED GASTROINTESTINAL DRUGS ON THE TERRITORY IN THE OVER-75S
29. T04.01.5 RELATIONSHIP BETWEEN ADALIMUMAB, PHARMACOKINETICS AND VITAMIN D-RELATED MARKERS
30. T04.01.4 USE OF ADALIMUMAB BIOSIMILAR ABP 501 IN CROHN'S DISEASE: AN OBSERVATIONAL STUDY
31. OC.12.6 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1
32. P613 Use of adalimumab biosimilar ABP 501 in Crohn’s disease: A real-life experience
33. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference
34. H2-breath testing for carbohydrate malabsorption
35. Italian nationwide survey of pharmacologic treatments in diverticular disease: Results from the REMAD registry
36. Diagnostic delay: assessment, improvement and outcome consequences in inflammatory bowel disease
37. AISF position paper on HCV in immunocompromised patients
38. Antibodies toMycobacterium paratuberculosis in patients with Crohn's disease
39. Safety and efficacy of azathioprine in the maintenance of ciclosporin-induced remission of ulcerative colitis
40. CHRONIC HEPATITIS DUE TO HCV, MIXED CRYOGLOBULINEMIA AND CARPAL TUNNEL SYNDROME: A CASE-CONTROL STUDY
41. OC. 12.4 PRIMARY SCLEROSING CHOLANGITIS ASSOCIATED WITH INFLAMMATORY BOWEL DISEASE: ANALYSIS OF INTESTINAL OUTCOME AFTER LIVER TRANSPLANTATION
42. P0600 NEUROENDOCRINE TUMORS OF THE GASTROINTESTINAL TRACT ARISING IN INFLAMMATORY BOWEL DISEASES: MORE THAN A COINCIDENCE?
43. Programmed Cell Death Ligand-1 (PD-L1) Expression is Coupled with Microsatellite Instability in Non-Familial Small Bowel Carcinomas Associated or not with Coeliac Disease or Crohn's Disease: Results from the Small Bowel Cancer Italian Consortium
44. PC.01.4 PREVALENCE OF ANAEMIA IN INFLAMMATORY BOWEL DISEASE: PRELIMINARY RESULTS OF THE OBSERVATIONAL ITALIAN MULTICENTRE IG-IBD STUDY RIDART 1
45. P.02.12 PREDICTIVE VALUE OF THE “DICA” ENDOSCOPIC CLASSIFICATION ON THE OUTCOME OF DIVERTICULAR DISEASE OF THE COLON: A 1-YEAR ANALYSIS FROM THE INTERNATIONAL, MULTICENTER, PROSPECTIVE STUDY
46. OC.03.3 THE “DICA” ENDOSCOPIC CLASSIFICATION FOR DIVERTICULAR DISEASE OF THE COLON SHOWS A SIGNIFICANT INTEROBSERVER AGREEMENT AMONG COMMUNITY ENDOSCOPISTS
47. P310 Diagnostic delay: assessment, improvement and outcome consequences in inflammatory bowel disease
48. Beclomethasone dipropionate enemas versus prednisolone sodium phosphate enemas in the treatment of distal ulcerative colitis
49. Controlled trial of oral 5-aminosalicylic acid for the prevention of early relapse in Crohn's disease
50. Detection of anti- Saccharomyces cerevisiae antibodies in Crohn's disease: is it reliable diagnostic and prognostic marker?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.